Results 241 to 250 of about 21,248 (301)
ABSTRACT Mosunetuzumab plus polatuzumab vedotin has shown promising activity versus rituximab plus polatuzumab vedotin (R‐Pola) in patients with relapsed/refractory (R/R) large B‐cell lymphoma (LBCL; NCT03671018). We present results from the Phase II randomized cohort, evaluating subcutaneous mosunetuzumab plus polatuzumab vedotin (Mosun‐Pola), with ...
Julio C. Chavez +17 more
wiley +1 more source
Key aspects of the Saudi healthcare system reform and the potential impact on the main stakeholders: A qualitative study. [PDF]
Al-Nozha OM.
europepmc +1 more source
Making Big Business Everybody's Business: Aboriginal leaders' perspectives on commercial activities influencing aboriginal health in Victoria, Australia. [PDF]
Crocetti AC +7 more
europepmc +1 more source
Child and adolescent mental health services in Aotearoa New Zealand. [PDF]
Miller E, James A.
europepmc +1 more source
Letters of recognition: the spatial inscription of literature in the Romanian street nomenclature. [PDF]
Rusu MS, Baghiu S.
europepmc +1 more source
Neoliberalism in academia: reflections from a parasitologist. [PDF]
Gasser RB.
europepmc +1 more source

